Hanna Taipaleenmaki PhD

Hanna Taipaleenmaki (PhD) is a Professor at the Faculty of Medicine at the Ludwig-Maximilian-University (LMU) in Munich, Germany. During her PhD training at the University of Turku, Finland, and at the Endocrine Research Unit, Odense University Hospital, Denmark, she investigated the post-transcriptional regulation of osteoblast differentiation and bone formation by non-coding RNAs.

During her post-doctoral training at the University of Massachusetts Medical School, USA, and at the University Medical Center Hamburg-Eppendorf, Germany, she further elucidated the contribution of microRNAs in pathological bone remodeling with a focus on cancer-induced bone disease. Funded by an excellence program of the German Research Foundation (DFG), she established her own research group at the University Medical Center Hamburg-Eppendorf in Hamburg, Germany, focusing on breast cancer-induced metastatic bone disease and muscle weakness under various conditions of bone loss. Her work has been recognized by several prestigious awards and published in top-tier scientific journals.

Dr. Taipaleenmaki is an active member of several scientific societies. She serves on the Board of the ECTS, was Chair of the ECTS Academy, and a member of the Early Stage Career Committee of the ASBMR, among others. Furthermore, Dr. Taipaleenmäki is an Editorial Board Member of several journals, including JBMR, and a reviewer of numerous scientific journals.